Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CLCN7 antisense RNA 1 (CLCN7-AS1)
- Target
- CLCN7-AS1
- Molecular classification
- Long non-coding RNA (lncRNA), Antisense RNA
01
Overview
CLCN7 antisense RNA 1 (CLCN7-AS1) is a long non-coding antisense RNA transcribed from the genomic region opposite the CLCN7 (Chloride voltage-gated channel 7) gene. Like many lncRNA antisense transcripts, CLCN7-AS1 is believed to regulate the expression of its sense gene (CLCN7) either via direct RNA-RNA interaction, by influencing chromatin status, or by interacting with protein complexes; these activities can occur in cis or trans depending on the lncRNA and cell type[3][6]. Although other antisense lncRNAs are known to modulate disease-relevant pathways and gene expression, specific experimental evidence about the molecular function or disease involvement of CLCN7-AS1 itself is lacking. Note: Most results and deeper disease and functional information focus on the CLCN7 protein itself, a validated transporter associated with osteopetrosis and lysosomal biology[1][2][4][5][7]. CLCN7-AS1, as an lncRNA, is not a typical or direct therapeutic target, and no drugs or biomarker roles are currently known.
- Other names
- CLCN7-AS1CLCN7 antisense RNA 1
02
Biological functions
Regulation of gene expression (particularly in cis at the CLCN7 locus)Potential modulation of mRNA stability, transcription, or chromatin state
03
Disease associations
Not a primary driver, but by modulating CLCN7, may be involved in diseases linked to CLCN7 (e.g., osteopetrosis, neurodegeneration), though direct disease roles of the lncRNA are not currently established
Beyond the preview
Go deeper on CLCN7 antisense RNA 1 (CLCN7-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CLCN7 antisense RNA 1 (CLCN7-AS1).